Login to Your Account

Waksal Subpoenaed; ImClone To Face House Subcommittee

By Kim Coghill

Thursday, June 6, 2002
WASHINGTON - Former ImClone Systems Inc. CEO Samuel Waksal has been subpoenaed by a House subcommittee to answer questions surrounding the business transactions and development of the investigational cancer drug Erbitux. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription